Evidence map›Paper›PMID 31484506›Full record

ArticleBMC nephrology2019

Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.

Jianzhen Zhang, Helen G Healy, Sree Krishna Venuthurupalli, Ken-Soon Tan, Zaimin Wang, Anne Cameron, Wendy E Hoy

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Disparities in Prevalence and Barriers to Hypertension Control: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jianzhen ZhangLevel 8, Health Sciences Building, Building 16/901, Royal Brisbane & Women's Hospitals, Herston, Brisbane, Queensland, 4029, Australia. jenny.zhang@uq.edu.au.ORCID 0000-0003-2914-2785
Helen G HealyKidney Health Service (Royal Brisbane and Women's Hospital), Metro North Hospital and Health Service, Brisbane, Queensland, 4029, Australia.
Sree Krishna VenuthurupalliKidney Health Service (Toowoomba Hospital), Darling Downs Hospital and Health Service, Toowoomba, 4350, Queensland, Australia.
Ken-Soon TanKidney Health Service (Logan Hospital), Metro South Hospital and Health Service, Logan, 4131, Queensland, Australia.
Zaimin WangLevel 8, Health Sciences Building, Building 16/901, Royal Brisbane & Women's Hospitals, Herston, Brisbane, Queensland, 4029, Australia.
Anne CameronLevel 8, Health Sciences Building, Building 16/901, Royal Brisbane & Women's Hospitals, Herston, Brisbane, Queensland, 4029, Australia.
Wendy E HoyLevel 8, Health Sciences Building, Building 16/901, Royal Brisbane & Women's Hospitals, Herston, Brisbane, Queensland, 4029, Australia.
Royal Brisbane and Women's Hospital · AULogan Hospital · AUToowoomba Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh blood pressure is the most significant risk factor for the development and progression of chronic kidney disease (CKD). Lowering blood pressure is a goal to prevent CKD progression. This study of adults with CKD who have hypertension aimed to determine blood pressure control rates and the treatment patterns of hypertension and to explore factors associated with control of hypertension.

methodsThis cross-sectional study included all non-dialysis people with CKD stages 3A to 5 under nephrology care in three public renal clinics in Queensland, who joined the CKD.QLD registry from May 2011 to Dec 2015 and had a history of hypertension. Demographic information, other health conditions, laboratory markers and anti-hypertensive medications in use at consent were extracted from the registry.

resultsAmong 1814 CKD people in these three sites in the registry who were age ≥ 18 years and had CKD stage 3A to 5, 1750 or 96% had a history of hypertension. Of these, the proportion with BP control to < 140/90 mmHg was 61.7% and to < 130/80 mmHg was 36.3%. With target BP < 140/90 mmHg or < 130/80 mmHg, participants aged ≥65 years were 1.23 (95% CI 1.06-1.42) or 1.12 (1.03-1.22) times more likely to have uncontrolled BP compared to those < 65 years old. Participants with severe albuminuria or proteinuria were 1.58 (1.32-1.87) or 1.28 (1.16-1.42, p < 0.001) more likely to have uncontrolled BP compared to those without significant albuminuria or proteinuria. Participants who had cardiovascular disease (CVD) were less likely to have uncontrolled BP compared to those without CVD (0.78, 0.69-0.89 or 0.86, 0.80-0.92). Factors associated with use of more classes of antihypertensive medicines among participants with uncontrolled BP (> 140/90 mmHg) were older age, diabetes, CVD, obesity and severe albuminuria/proteinuria (p < 0.05). Renin Angiotensin Aldosterone System inhibitors were the most frequently used medicines, regardless of the number of medicine classes an individual was prescribed.

conclusionsBlood pressure control rates in these hypertensive people with CKD was still far from optimal. People with CKD and hypertension aged 65 or older or with severe albuminuria or proteinuria, a group at risk of progression of kidney disease, have higher rates of uncontrolled BP.

Indexed as

Disease ManagementAdolescentAdultAgedAntihypertensive AgentsBlood PressureBlood Pressure DeterminationCross-Sectional StudiesFemaleHumansHypertensionMiddle AgedQueenslandRegistriesRenal Insufficiency, ChronicYoung AdultAntihypertensive AgentsAnti-hypertensive medicationsBlood pressure controlChronic kidney diseaseCKD.QLD registryHypertensionRisk factors

Identifiers

PMID31484506
PMCPMC6727367
OpenAlexW2771162935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.